Why Do SARMs Taste So Bad?

Key takeaways

The Short Answer

Selective androgen receptor modulators (SARMs) are not approved by the U.S. Food and Drug Administration for any medical use, and products sold online as SARMs are not manufactured, tested, or formulated the way an approved oral medicine would be. Some products marketed as SARMs are labeled as dietary supplements, while others carry statements such as "Not for human consumption" or "Research use only," reflecting the fact that they fall outside normal pharmaceutical manufacturing standards. The taste problem reported by users has three overlapping sources: the cosolvent used to turn a poorly water-soluble powder into a liquid, the inherent bitterness of many small, nitrogen-containing, aromatic drug-like molecules, and the absence of taste-masking excipients, flavoring, or coating that would normally be engineered into an approved drug product during formal development and regulatory review.

Why Do Liquid SARMs Taste So Bitter? Largely the Solvent

Most SARM active ingredients are sold as raw crystalline powder that does not dissolve well in water, so sellers and hobbyist "homebrewers" dissolve it in an industrial cosolvent to make a measurable liquid. Online guides describing this process commonly recommend polyethylene glycol (PEG-300 or PEG-400), dimethyl sulfoxide (DMSO), propylene glycol, or grain alcohol as the base solvent, with one guide noting that "Propylene Glycol is another popular option" because it is easy to source. PEG 400 itself is a well-characterized pharmaceutical excipient: it is a clear, colorless, viscous liquid that is strongly hydrophilic, and it is used in various pharmaceutical formulations in part because of its low toxicity profile. That does not make it palatable; it is a functional solubilizing agent, not a beverage base, and it carries its own characteristic thickness and chemical aftertaste.

Within do-it-yourself SARM-liquid communities, the taste problem is acknowledged directly rather than disputed. One frequently cited homebrew guide states that adding vegetable glycerin will thicken the liquid and improve the taste, which is effectively an admission that the base solvent, not only the dissolved compound, contributes heavily to the unpleasant mouthfeel. Another widely circulated mixing guide is blunter still, warning users that the finished liquid will still taste awful and that they will have to get used to the unpleasant flavor. These are amateur formulations assembled outside any pharmaceutical quality system, so there is no standardized recipe, no consistency between batches, and no taste-masking science applied at any stage.

None of this means these solvents are inherently dangerous at the concentrations used in legitimate pharmaceutical products. The point is narrower: these liquid SARM products are compounded informally, without the quality control, dosing precision, or excipient science that goes into an actual approved oral drug.

The Molecules Themselves: Why Many Drug-Like Compounds Taste Bitter

Even a chemically pure SARM powder dissolved in a neutral solvent would likely taste unpleasant, because bitterness is a general property shared by many small synthetic and plant-derived molecules. Bitter taste in humans is detected by a family of roughly 25 G-protein-coupled receptors called TAS2Rs. In the most frequently cited systematic screening of this receptor family, researchers challenged all 25 human TAS2Rs with 104 natural and synthetic bitter chemicals in a heterologous expression system, and in doing so identified thirteen new cognate bitter compounds for five previously "orphan" receptors plus sixty-four additional compounds for receptors whose agonists were already partly known. That work, and later structural studies, found that some receptors are narrowly tuned while others, such as TAS2R14, respond to well over 100 topographically diverse agonists, which helps explain how a limited number of receptors can flag thousands of chemically unrelated bitter substances.

These receptors are not confined to the tongue. TAS2Rs are also expressed at extra-oral sites including the gastrointestinal tract, thyroid, lung, heart, brain, and immune cells, indicating a broader chemosensory role beyond the initial experience of taste in the mouth. The prevailing evolutionary explanation is that this receptor family evolved on the tongue as a repulsive system to help avoid the ingestion of plant toxins, which is consistent with the fact that TAS2Rs respond broadly to nitrogen-containing rings, amide groups, and other structural motifs common to both natural toxins and synthetic pharmaceuticals.

No published study has specifically screened SARM compounds against the human TAS2R receptor panel, so it is not possible to state precisely which receptors any individual SARM activates or how strongly. What can be said, based on the general pharmacology and taste-receptor literature, is that the aromatic and heterocyclic character typical of SARM chemical scaffolds is broadly consistent with known bitter-agonist patterns, which makes the near-universal bitterness reported for SARM products unsurprising in that context. This is a reasonable extrapolation from receptor biology, not a directly tested finding for this drug class, and it should be weighed accordingly as indirect evidence.

No Approved Formulation Means No Taste-Masking

Legitimate oral medicines routinely use film coatings, sweeteners, flavoring agents, and other excipients chosen during drug development specifically to make a bitter active ingredient tolerable to swallow. Building that kind of formulation requires regulatory review, stability testing, and manufacturing standards that apply to approved drugs. No SARM has cleared that bar: to date, no SARM has been approved by the FDA for any medical use, and the FDA has stated that SARMs cannot be legally marketed in the United States as a dietary supplement or drug. Some products marketed as SARMs carry supplement-style labeling while others are labeled "Not for human consumption" or "Research use only", language that exists in part because these products have not been developed, tested, or packaged as something intended to be consumed by people. There is no regulatory requirement or standard industry practice pushing sellers of these compounds to invest in taste-masking, because the products are not legally sold as ingestible medicines in the first place.

Purity, Contamination, and Why Taste Varies Between Bottles and Batches

A related issue is that the actual chemical content of products sold online as SARMs has repeatedly been shown to vary in ways unrelated to any consistent formulation. A 2017 investigation published in JAMA analyzed the chemical composition of 44 products purchased online and marketed as SARMs; only 52% of them actually contained a SARM, and an additional 39% contained an unapproved substance unrelated to SARMs, such as the growth hormone secretagogue ibutamoren, the PPAR-delta agonist cardarine (GW501516), or the Rev-Erbα agonist SR9009. Later reviews summarizing this and related work have described the resulting mislabeling as substantial across the market.

A separate investigation of illegal SARM products purchased online and accessible from Italy analyzed thirteen products using mass spectrometry and quantitative nuclear magnetic resonance. Quantitative content ranged from 30% to 90% of the amount stated on the label, more than one active substance was present together in over 60% of samples, and undeclared pharmaceutical substances, including tamoxifen, clomifene, testosterone, epimethandienone, and tadalafil, were measured in roughly 30% of samples. A summary of a separate 2020 analysis published in the journal Drug Testing & Analysis reported that researchers examined 20 dietary supplements sold as containing SARMs and found that only six of the twenty samples were consistent with their labeling, with additional discrepancies between measured concentrations and what was printed on the packaging where a SARM was detected at all.

Given this level of inconsistency in identity, concentration, and co-contamination across products claiming to contain the same compound, it follows that taste, smell, and mouthfeel would also vary unpredictably from bottle to bottle and batch to batch, since the underlying solvent ratios, active-ingredient concentrations, and unlisted contaminants are themselves inconsistent. This is a logical inference from the contamination data rather than a directly measured finding about taste variability itself.

Does a Bitter Taste Mean a Product Is Pure, Potent, or Fake?

No peer-reviewed study has established a relationship between the intensity of bitterness in a SARM product and its purity, potency, or authenticity; the evidence on this specific question is essentially absent rather than merely thin. Bitterness, as described above, is driven largely by the choice and concentration of solvent along with the general chemical class of the compound, not by how much active ingredient is present or whether that ingredient matches the label. Given the documented rates of mislabeling, under- or over-dosing, and outright substitution found across independent laboratory analyses of products marketed as SARMs, taste cannot function as a meaningful proxy for verifying what is actually in a bottle. The methods that have reliably distinguished labeled from mislabeled or contaminated products in the literature are analytical chemistry techniques such as liquid chromatography-tandem mass spectrometry and nuclear magnetic resonance spectroscopy, the same methods used in the JAMA and Italian investigations described above.

FDA Status and Health Risks Beyond the Taste Issue

Whatever a given SARM product tastes like, its regulatory and safety status is unambiguous. No SARM has been approved by the FDA for any medical use, and SARMs, described by the FDA as chemical substances that mimic the effects of testosterone and anabolic steroids, are not FDA approved. The agency has continued to issue public warnings, including one directed specifically at bodybuilding-type products marketed to teens and young adults through social media, noting that online vendors and influencers use social media to make SARMs appear safe and effective when they are not. The FDA states that studies and reports show SARMs are associated with serious or life-threatening health problems, including increased risk of heart attack or stroke, psychosis or hallucinations, sleep disturbances, sexual dysfunction, liver injury and acute liver failure, infertility, pregnancy miscarriage, and testicular shrinkage. Separately, a review of suspected adverse event reports found that since 2020, twenty published reports have described adverse events, most involving drug-induced liver injury, associated with SARM use. Many SARM products are sold with no warning labels at all, which public-health summaries of the FDA's position note may lead consumers to mistakenly believe the products are safe.

SARMs as a class have also been included on the World Anti-Doping Agency's list of prohibited substances for more than a decade, reflecting their androgenic, performance-enhancing pharmacology rather than any established safety or efficacy profile. None of this is related to how a product tastes: an unpleasant flavor is not evidence of potency or purity, and a milder or more palatable-tasting liquid is not evidence of safety, legality, or accurate labeling. The taste of a SARM product says something about the solvent chosen and the general chemistry of bitter-tasting molecules; it says nothing reliable about what is actually inside the bottle or about the substantial, well-documented health risks associated with using these unapproved substances.

Frequently asked

References